Richard S. Judson
Chief Tech/Sci/R&D Officer at Genaissance Pharmaceuticals, Inc.
Profile
Richard S.
Judson has been Senior Vice President and Chief Scientific Officer of Genaissance Pharmaceuticals, Inc. since September 2003.
He was Senior Vice President of Informatics for Genaissance Pharmaceuticals from April 2000 to August 2002.
Prior to joining Genaissance Pharmaceuticals in February 1999, he was Group Leader in the Bioinformatics Department of CuraGen Corp.
from January 1997 to February 1999.
Dr. Judson received a BA degree from Rice University and an MA as well as a PhD from Princeton University.
Richard S. Judson active positions
| Companies | Position | Start |
|---|---|---|
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Chief Tech/Sci/R&D Officer | 1999-01-31 |
Former positions of Richard S. Judson
| Companies | Position | End |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | 1999-01-31 |
Training of Richard S. Judson
| Rice University | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Stock Market
- Insiders
- Richard S. Judson
